Rubicon Research: Merger of WOS Kia Health Tech approved by Board

Rubicon Research Ltd's Board of Directors approved the scheme of merger of its wholly-owned subsidiary, Kia Health Tech Pvt Ltd, with the parent company on July 20, 2026. The merger is being carried out under Section 233 of the Companies Act, 2013. This scheme solely involves the merger of the subsidiary with the parent and does not entail any change in the company's shareholding pattern, issuance of new shares, or payment of consideration. Rubicon Research is exempt from obtaining prior approval or a no-objection letter from stock exchanges for this merger, as per Paragraph 4 of the SEBI Master Circular dated June 20, 2023, which applies to mergers of wholly-owned subsidiaries with their parent companies. The filing is made solely for disclosure purposes.